-
Gland Pharma
2,826.60 1,575.00(%) -
Tata Technolog.
830.10 890.15(%) -
IFCI
103.95 101.60(%) -
HFCL
231.40 257.00(%) -
Lumino Inds
122.00 119.00(%) -
Jindal Worldwide
57.06 47.55(%) -
Netweb Technol.
5,424.00 5,810.00(%) -
Angel One
308.20 360.20(%) -
HBL Engineering
723.85 1,121.95(%) -
Multi Comm. Exc.
3,257.00 3,479.80(%) -
Adani Total Gas
620.85 859.70(%) -
Lenskart Solut.
694.75 680.95(%) -
Oberoi Realty
1,932.25 1,985.00(%) -
RBL Bank
413.50 410.45(%) -
Tejas Networks
613.50 644.75(%) -
Polycab India
8,308.55 6,660.50(%) -
Antelopus Selan
986.05 357.00(%) -
Nuvoco Vistas
353.50 477.35(%) -
One 97
1,691.50 1,732.00(%) -
Reliance Industries
1,332.30 1,611.20(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Global Health Ltd Healthcare
- Indian Private
- BSE Code : 34649.0
- ISIN : INE474Q01031
-
Today’s Low
1,410.00 -
Today’s High
1,471.50
-
Open
1,444.90 -
Perv Close
1,444.90 -
52W Low
956.00 -
52W High
1,544.00
Key Indicators
-
P/E(TTM)
76.78
-
Mar.Cap (₹Cr.)
38,107.20
-
Div & Yield %
0.04
-
Book Value(₹)
149.24
-
Debt-Equity Ratio
-1.91
-
AGM Date
03-Sep-2026
-
EPS
18.48
-
P/E Ratio
76.78
Financials Ratios
-
Debt-Equity Ratio
0.36
-
Mar.Cap (₹Cr.)
38,107.20
-
RONW (%)
17.93
-
ROCE (%)
18.96
Score Board
-
Equity (₹ in Cr.)
53.77
-
BV (₹)
149.20
-
Sales( ₹ in Cr.)
3,709.38
-
NP (in Cr.)
495.64
-
NP Var(%)
-1.0
-
Div%
25.0
-
CPS (₹)
24.80
-
EPS (₹)
18.40
-
Traded Value (₹ in Lakhs)
38,148.87
-
52 Week High
1,544.00
-
52 Week Low
956.00
-
Price BSE
1419.0
-
Price NSE
1,417.00
-
Market Capital( in Cr.)
38,148.87
-
P/C Ratio
57.20
-
P/E Ratio
77.00
-
Price Vs.BV
18.40
-
30-Jul-2026( 09:17)
Corporate News - Globa... - Global Health Limited, which o...
-
30-Jul-2026( 01:43)
Corporate News - Globa... - Global Health Limited announce...
-
30-Jul-2026( 05:36)
Results - Announcements - Globa... - Net profit of Global Health de...
-
21-Jul-2026( 09:43)
Corporate News - Globa... - Global Health will hold a meet...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 3,709.38 | 3,204.15 | 2,974.72 | 1,973.54 | 1,764.96 | 1,227.40 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 3,709.38 | 3,204.15 | 2,974.72 | 1,973.54 | 1,764.96 | 1,227.40 |
| Other Income | 126.00 | 90.81 | 90.59 | 47.59 | 35.04 | 28.35 |
| Stock Adjustments | -4.61 | -2.62 | -1.48 | 0.41 | 2.79 | 3.42 |
| Total Income | 3,830.77 | 3,292.34 | 3,063.83 | 2,021.54 | 1,802.79 | 1,259.17 |
| EXPENDITURE : | ||||||
| Raw Materials | 787.80 | 756.20 | 698.03 | 459.11 | 451.23 | 301.73 |
| Power and Fuel Cost | 59.52 | 53.90 | 52.76 | 36.84 | 31.80 | 27.43 |
| Employee Cost | 989.26 | 746.29 | 678.72 | 532.91 | 494.66 | 415.91 |
| Other Manufacturing Expenses | 87.97 | 67.13 | 61.34 | 74.21 | 52.31 | 8.63 |
| Selling and Administration Expenses | 953.30 | 742.11 | 654.34 | 411.71 | 327.42 | 271.25 |
| Miscellaneous Expenses | 82.53 | 113.38 | 75.08 | 37.15 | 29.54 | 32.95 |
| Employee Benefit Expenses | 989.26 | 746.29 | 678.72 | 532.91 | 494.66 | 415.91 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 2,960.39 | 2,479.01 | 2,220.28 | 1,551.92 | 1,386.96 | 1,057.90 |
| Operating Profit | 870.38 | 813.33 | 843.56 | 469.62 | 415.83 | 201.26 |
| Interest | 49.82 | 40.67 | 50.78 | 31.82 | 32.83 | 29.20 |
| Gross Profit | 820.56 | 772.66 | 792.78 | 437.80 | 383.00 | 172.06 |
| Depreciation | 170.91 | 149.61 | 133.93 | 86.09 | 87.17 | 87.64 |
| Profit Before Tax | 649.65 | 623.05 | 658.85 | 351.71 | 295.83 | 84.42 |
| Current Tax | 131.24 | 161.55 | 178.97 | 97.36 | 85.66 | 27.14 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 22.21 | -0.03 | -6.47 | -8.90 | -8.62 | 0.00 |
| Reported Net Profit | 496.20 | 461.53 | 486.35 | 263.25 | 218.78 | 57.29 |
| Extraordinary Items | 0.56 | -36.86 | 0.60 | -0.49 | 0.19 | 0.59 |
| Adjusted Net Profit | 495.64 | 498.39 | 485.75 | 263.74 | 218.59 | 56.70 |
| Adjustment below Net Profit | 3.33 | -0.97 | 49.93 | 1.16 | -2.35 | 2.48 |
| P & L Balance brought forward | 2,359.68 | 1,895.78 | 1,356.17 | 1,088.43 | 882.00 | 822.23 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 13.44 | -3.33 | -3.33 | -3.33 | 10.00 | 0.00 |
| P & L Balance carried down | 2,845.77 | 2,359.68 | 1,895.78 | 1,356.17 | 1,088.43 | 882.00 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 25.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 18.47 | 17.18 | 18.11 | 9.82 | 8.64 | 11.55 |
| Earnings Per Share(Adj)-Unit Curr | 18.47 | 17.18 | 18.11 | 9.82 | - | - |
| Book Value | 149.34 | 130.22 | 113.11 | 92.80 | 68.70 | 292.65 |
| Book Value(Adj)-Unit Curr | 149.34 | 130.22 | 113.11 | 92.80 | - | - |
